Appendix C

Biographical Sketches of Committee Members

Dr. Joseph A. Buckwalter, M.D., is professor of orthopedics and rehabilitation and the Arthur Steindler Chair of Orthopaedics at the University of Iowa. He served as head of the department for 14 years and as senior editor of the Journal of Orthopaedic Research for more than 25 years. His clinical practice includes treatment of patients with osteoarthritis, joint injuries, and tumors of the skeleton and musculoskeletal soft tissues. He has served as chairman of the American Academy of Orthopaedic Surgeons Council on Research and president of the Orthopaedic Research Society, the American Board of Orthopaedic Surgery, and the American Orthopaedic Association. His research awards include the Kappa Delta Award, the Cabaud Award for Research in Sports Medicine, the American Orthopaedic Association Award for Distinguished Achievement in Orthopaedic Research, the Orthopaedic Research Society and American Orthopaedic Association Alfred Shands Award for Research, and the Orthopaedic Research Society–Orthopaedic Research and Education Foundation Distinguished Investigator Award. He is a member of the Royal College of Surgeons of Edinburgh and the National Academy of Medicine of the National Academies of Sciences, Engineering and Medicine. His current research involves study of the pathogenesis of posttraumatic osteoarthritis and methods of preventing osteoarthritis following joint injuries. His most recent work shows that mechanically induced chondrocyte metabolic dysfunction has a critical role in the onset and progression of mechanically induced osteoarthritis and that preventing this chondrocyte dysfunction in animal models that simulate human joint injuries minimizes or prevents cartilage erosion following joint injury.

Dr. Aline Charabaty, M.D., A.G.A.F., F.A.C.G., is the assistant clinical director of the Gastrointestinal (GI) Division at Johns Hopkins School of Medicine and the clinical director of the Inflammatory Bowel Diseases (IBD) Center at Johns Hopkins-Sibley Memorial Hospital in Washington D.C. She completed her medical school at St. Joseph University in Lebanon and her internal medicine residency and GI fellowship at Georgetown University Hospital, where she joined the GI faculty and established and led the IBD Center for 13 years before joining the Johns Hopkins School of Medicine faculty in January 2019. Dr. Charabaty was the chair of the Greater Washington, D.C./Virginia Crohn’s and Colitis Foundation Mission Committee from 2012 to 2019 and served on the foundation’s national scientific advisory committee’s patient education committee and physician education committee. She was recognized for her work for the IBD community in 2020 when she received the Excellence in Medicine Award. She currently serves on the foundation’s diversity and inclusion committee and on the Northeast Regional Planning Committee for patients education programs. Dr. Charabaty has numerous peer-reviewed publications and is an invited speaker at regional, national, and international conferences. She is also actively involved in educational and advocacy activities and committees with national and international GI societies. She is the American College of Gastroenterology (ACG) Governor of Washington, D.C., and a member of the ACG Legislative and Public Policy Council, and she represents the ACG at the Digestive Disease National Coalition. She was the co-director of the ACG Eastern Regional Course in 2021. She served as a member of the American Gastroenterological Association (AGA) diversity committee and is currently serving on the AGA government affairs committee. Dr. Charabaty serves on the editorial board of the CC360 online journal of the Crohn’s and Colitis Foundation and on the board of Gastroenterology & Endoscopy News. Dr. Charabaty also uses social media as a medium for medical education and advocacy for the profession of GI and for patients. She is the founder of @MondayNightIBD, a twitter forum that brings clinicians together to discuss the management of complex IBD cases. She received the Healio Gastroenterology Disruptive Innovator Award for this initiative during ACG 2019. Dr. Charabaty is a strong advocate for improved access to care for GI and IBD patients and an advocate for diversity in GI, for women in medicine, and for work–life integration. She was selected as one of the Washingtonian Top Doctors by her peers on consecutive years. Dr. Charabaty advises pharmaceutical companies, including AbbVie, Takeda, Pfizer, Janssen, and Bristol Myers Squibb, on therapeutics for inflammatory bowel diseases.

Dr. Melissa Davis, M.D, M.B.A., is an assistant professor at Yale School of Medicine where she also serves as Vice Chair of Informatics in the

Radiology Department. She completed her B.A. in chemistry and psychology at Wellesley College in Wellesley, Mass. In 2009 she received her medical degree from the Medical University of South Carolina in Charleston, S.C. Subsequently she completed a diagnostic radiology residency and a neuroradiology fellowship at the University of North Carolina in Chapel Hill, N.C. Dr. Davis obtained her M.B.A. in 2017 from Yale University with a focus in health care management. Since completing her M.B.A., Dr. Davis has focused her professional and academic areas of interests in organizational change and innovation within the health care space. As a physician, her core objective is to serve the needs of the patient. To wholly serve the patient requires more than the interaction at the point of care, but rather creating and functioning within a system built to support the patient and providers. This has driven the early focus in her career on operational work-flows and improving quality within the inpatient and ambulatory spaces through innovative approaches and new technologies.

Dr. Jill de Jong, M.D., Ph.D., treats children with all types of cancers and blood diseases as well as hematopoietic stem cell transplant patients. She has specialized expertise in hematology, including disorders of red blood cells, white blood cells, and platelets; autoimmune blood diseases; bleeding and clotting disorders; and genetic (inherited) blood diseases. Dr. de Jong’s research focuses on understanding genetic syndromes that predispose patients to bone marrow failure or cancer. By studying known genetic mutations that lead to cancer and uncovering new cancer predisposition syndromes, her work examines the mechanisms that cause cancer in order to improve cancer therapies. Through her research, she aims to optimize early detection, treatment, and, ultimately, prevention of cancer and bone marrow disorders.

Dr. Suzanne Groah, M.D., M.S.P.H., is the director of the SCI Rehabilitation and Recovery Program and Director of Spinal Cord Injury (SCI) Research at MedStar NRH and also a professor of rehabilitation medicine at Georgetown University. She served on the board of directors of the American Spinal Injury Association from 2010 to 2016 and since 2017 has served as an officer of the organization. She has a subspecialty certification in SCI medicine from the American Board of Physical Medicine and Rehabilitation and was a writer for the SCI subspecialty examination from 2006 to 2015. Dr. Groah has had continual research funding since 2003, was the project director of two rehabilitation research and training centers (RRTCs) on secondary conditions after SCI (2003–2016) and the National Capital SCI Model System (2006–2011), and is currently project director of the RRTC on Neurogenic Lower Urinary Tract Dysfunction and the National Capital Spinal Cord Injury Model System, both of which are designated centers of excellence. She also has had funding by the Craig H. Neilsen Foundation

and the Department of Defense. She is an associate editor of the advanced SCI text, Spinal Cord Injury Medicine, published in 2019, and serves as the co-editor-in-chief of the journal, Topics in SCI Rehabilitation. She was co-chair of the Paralyzed Veterans of America (PVA) Consortium Guideline on Carbohydrate and Lipid Disorders after SCI and was an expert panel member for the PVA Consortium Guideline on Bladder Management. She has published more than 50 peer-reviewed articles. After completing residency in physical medicine and rehabilitation at the Medical College of Virginia, Dr. Groah completed two fellowships (aging with SCI research and clinical neurorehabilitation), both at Craig Hospital. She received her M.S.P.H. from the University of Colorado at the same time.

Dr. Amy Houtrow, M.D., Ph.D., M.P.H., is professor of physical medicine and rehabilitation and pediatrics and the Endowed Chair for Pediatric Rehabilitation Medicine in the Department of Physical Medicine and Rehabilitation at the University of Pittsburgh School of Medicine, where she also serves as the vice chair for quality and safety. She is the director of the Leadership Education in Neurodevelopmental Disabilities program at the University of Pittsburgh. For the University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh, Dr. Houtrow serves as the chief of pediatric rehabilitation medicine. Her research focuses on health care access and outcomes for children with disabilities with special emphasis on health equity. She has authored more than 150 manuscripts, written and edited textbooks, and developed training programs for physicians and other health care professionals, and she serves as a leader for numerous foundations and academic societies. In 2018 she was elected into the National Academy of Medicine.

Dr. Jonathan S. Lewin, M.D., is professor of radiology and imaging sciences, professor of biomedical engineering, and professor of neurosurgery in the Emory School of Medicine and professor of health policy and management in the Rollins School of Public Health. Until September 2022, he also served as the Executive Vice President for Health Affairs, Emory University; Executive Director, Woodruff Health Sciences Center; and CEO and Chairman of the Board, Emory Healthcare. Dr. Lewin is a national leader in academic medicine strategy and integrated health care delivery and an international scientific leader in interventional and intraoperative MRI. Dr. Lewin is a national leader in academic medicine strategy and integrated health care delivery and an international scientific leader in interventional and intraoperative magnetic resonance imaging (MRI). Prior to his Emory appointment, Dr. Lewin served as the Martin Donner Professor and chairman of the Russell H. Morgan Department of Radiology and Radiological Science at Johns Hopkins University and the radiologist-in-chief at Johns Hopkins Hospital from 2004 until 2016, with secondary appointments as professor

of oncology, neurosurgery, and biomedical engineering. From 2012 to 2016 he also served as co-chair for strategic planning and from 2013 to 2016 as senior vice president for integrated healthcare delivery for Johns Hopkins Medicine. Before joining the faculty of Johns Hopkins, Dr. Lewin was the director of the Division of Magnetic Resonance Imaging at University Hospitals of Cleveland and professor and vice chairman for research and academic affairs in the Department of Radiology at Case Western Reserve University. Dr. Lewin received his undergraduate degree in chemistry from Brown University in 1981 and his doctor of medicine from Yale University in 1985. Following his internship in pediatrics at Yale–New Haven Hospital and residency in diagnostic radiology at University Hospitals of Cleveland, he completed a magnetic resonance research fellowship in Germany, a neuroradiology fellowship at the Cleveland Clinic, and additional training in head and neck radiology at the Pittsburgh Eye and Ear Hospital. Dr. Lewin is a pioneer in interventional and intraoperative magnetic resonance imaging (MRI) and has published more than 200 peer-reviewed scientific manuscripts and more than 70 book chapters, reviews, commentaries, and other invited papers on topics including the basic science and clinical aspects of interventional MR imaging, functional MRI, head and neck imaging, MR angiography, and the imaging of acute stroke. Dr. Lewin holds 28 U.S. and seven international patents and has been principal investigatory (PI) or co-PI on National Institutes of Health (NIH) and other federal and state grants with awards of more than $54 million as well as a co-investigator on a number of other grants and projects. He is a fellow of the International Society for Magnetic Resonance in Medicine and of the American College of Radiology and has lectured around the world on a number of topics in magnetic resonance imaging, interventional radiology, neuroradiology, and leadership in academic medicine. He has served on numerous national committees, editorial boards, and grant review groups for foundations and the NIH and on the task force on minimally invasive cancer therapy for the National Cancer Institute. Dr. Lewin is past president of the Society of Chairs of Academic Radiology Departments, the American Roentgen Ray Society, the Association of University Radiologists, the International Society for Strategic Studies in Radiology, and the Academy for Radiology Research. Modern Healthcare named Dr. Lewin one of the 50 Most Influential Physicians of 2017. He was also named one of the Most Influential Atlantans of 2016, 2017, 2018, 2019, 2020, 2021, and 2022 by the Atlanta Business Chronicle; one of the 100 Most Influential Georgians of 2018, 2019, 2020, 2021, and 2022 by Georgia Trend; one of the Atlanta 500 by Atlanta Magazine in 2019, 2020, 2021, 2022, and 2023; and one of the Atlanta Business Chronicle’s Most Admired CEOs for 2020. He has received gold medal awards from three professional societies for distinguished service and contributions to the field of radiology (Radiology

Society of North America, the American Roentgen Ray Society, and the Association of University Radiologists), and he was the 2019 recipient of the National Medical Fellowships’ Pioneer Award. He is also a past recipient of the Radiology Research Alliance Innovation and Leadership Award as well as the Leadership Luminary Award from the Radiology Leadership Institute of the American College of Radiology. In 2019 he was elected a fellow of the National Academy of Inventors.

Dr. Roger Lewis, M.D., Ph.D., received his Ph.D. in biophysics and his M.D. from Stanford University. He is a senior physician in the Los Angeles County Department of Health Services, a professor of emergency medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), and the senior medical scientist at Berry Consultants, LLC, a group that specializes in innovative clinical trial design. He is also the former chair of the Department of Emergency Medicine at Harbor-UCLA Medical Center. Dr. Lewis’s expertise centers on adaptive and Bayesian clinical trials, including platform trials; translational, clinical, health services, and outcomes research methodology; data and safety monitoring boards; and the oversight of clinical trials. Dr. Lewis was elected to membership in the National Academy of Medicine in 2009. He has served as a member of the Blood Products Advisory Committee of the U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, the Medicare Evidence Development & Coverage Advisory Committee of the Centers for Medicare & Medicaid Services, and on multiple consensus committees of the National Academy of Medicine. He has chaired data and safety monitoring boards for numerous federally funded, industry-sponsored, and multinational clinical trials. He is the statistical editor for JAMA and an editor of the JAMA series entitled JAMA Guides to Statistics and Methods. Dr. Lewis has served as a content reviewer for many other peer-reviewed journals. He has authored or coauthored more than 270 original research publications, reviews, editorials, and chapters. Dr. Lewis has served as a grant reviewer for the Agency for Healthcare Research and Quality, the Canadian Institutes of Health Research, the Centers for Disease Control and Prevention, the UK Medical Research Council, the National Cancer Institute of France, the National Institutes of Health, the Patient-Centered Outcomes Research Institute, and foundations. During the US COVID-19 epidemic, Dr. Lewis served as the director of COVID-19 Demand Modeling for the Los Angeles County Department of Health Services, leading a multidisciplinary team developing epidemiological prediction models to aid in hospital preparedness and response. Dr. Lewis is a past president of the Society for Academic Emergency Medicine and served on the board of directors for the Society for Clinical Trials. He is a fellow of the American College of Emergency Physicians, the American Statistical Association, and the Society for Clinical Trials.

Dr. Viviany Taqueti, M.D., M.P.H., is a cardiologist, physician-investigator and Director of the Cardiac Stress Laboratory at Brigham and Women’s Hospital, Harvard Medical School. She is an expert in ischemic, cardiometabolic and inflammatory heart disease with a focus on coronary microvascular dysfunction. Her research pioneered the use of multimodality imaging technology to quantify coronary blood flow and atherosclerotic plaque to refine cardiovascular prognosis in patients with coronary heart disease, residual inflammation, obesity, diabetes and heart failure with preserved ejection fraction. Her portfolio of scholarship over a decade on faculty at Harvard Medical School has facilitated the clinical translation of advanced imaging biomarkers for discovery of pathogenic mechanisms in chronic coronary disease, including novel applications of multimodality imaging in the clinical evaluation of women’s heart disease and the development of national guidelines for the use of noninvasive imaging in the diagnosis of coronary microvascular dysfunction. This work has significantly impacted the landscape of clinical decision-making in ischemic heart disease. Dr. Taqueti graduated summa cum laude from Harvard University in biochemical sciences, magna cum laude from Harvard Medical School through the Harvard-MIT Division of Health Sciences and Technology, and completed internal medicine and cardiovascular medicine and imaging training at Massachusetts General Hospital and Brigham and Women’s Hospital. She has a master from the Harvard School of Public Health and executive training in healthcare leadership from Harvard Business School. She is board certified in Internal Medicine, Cardiovascular Disease, Echocardiography and Nuclear Cardiology. Dr. Taqueti is an elected member of the Faculty Council at Harvard Medical School, an associate member at the Broad Institute of MIT and Harvard and an advisor at Broadview Ventures, a mission-driven fund for impact investing in cardiovascular disease. She is immediate past-Chair of the Scientific Publications Committee and current Chair of the inaugural Digital Transformation Committee of the American College of Cardiology, overseeing the expansion to the 10 member JACC Journal portfolio and a $19 million dollar strategic project budget. She is on the Board of Directors of the American Society of Nuclear Cardiology, the Editorial Board of the European Heart Journal, a member of writing committees for the AHA/ACC Guidelines and the National Academy of Sciences, Engineering and Medicine, and a former editorial assistant at The New England Journal of Medicine. Her research is supported by federal and foundation sources including the National Institutes of Health and Harvard University. Her scholarly work comprises more than 90 scientific reports with more than 3,400 citations, a median citation percentile over 90 and relative citation ratio in the NIH 98-99th percentile. She is a contributing author for multiple book chapters on heart disease in women, cardiovascular imaging and coronary microvascular dysfunction, including Fuster and Hurst’s The Heart and a companion volume to Braunwald’s Heart Disease. She has

given more than 100 invited scientific lectures at national and international academic conferences.

Dr. Kathy Sietsema, M.D., is a professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) and the former chief of the Division of Pulmonary and Critical Care Medicine at Harbor–UCLA Medical Center. She attended the Northwestern University School of Medicine, had postgraduate training at the University of California, Davis, and the University of Washington, and fellowship training in pulmonary medicine at Harbor–UCLA Medical Center. Her academic interests are in the area of the use of exercise testing in clinical and research applications. Her work has included investigations into the nature and significance of functional impairment in a wide range of chronic disease states, including chronic heart failure, congenital heart diseases, chronic kidney disease, and pulmonary hypertension. She is the current organizer for the Practicum in Exercise Testing and Interpretation, a postgraduate conference conducted twice yearly at Harbor–UCLA continuously since 1982, and is a co-editor of a text on the topic of cardiopulmonary exercise testing.

Dr. Kim Williams, Sr., M.D., M.A.C.C., F.A.H.A., M.A.S.N.C., F.E.S.C., is currently the Chairman of Department of Medicine and the University of Louisville. He specializes in cardiology, cardio-nutrition, cardiorheumatology, cardio-nephrology, preventive cardiology and cardiovascular radiology. He is a past President of the American College of Cardiology, past President of the American Society of Nuclear Cardiology, and former Chairman of the Board of Directors of the Association of Black Cardiologists. He is also the founder of the Urban Cardiology Initiative in Detroit, Michigan, aiming to reduce ethnic heart care disparities, and continued community-based efforts in Chicago at Rush, including the H.E.A.R.T. program (Helping Everyone Assess Risk Today), screening for heart disease and intervening with education, nutrition and lifestyle changes. He has been a delegate for cardiology to the American Medical Association for more than 20 years and has served as a consultant for the FDA and Centers for Medicare and Medicaid Services. His current professional focus is on preventive cardiology, synthesizing data on cardiovascular risk and mortality due to nutrition, as an internationally recognized speaker. He has more than 600 research and guideline publications, online resources, movies and lectures, most recently on the topic of cardionutrition. He is the founding Editor-in-Chief of the International Journal of Disease Reversal and Prevention. Dr. Williams has more than 40 years of experience as an educator, researcher, and clinician focused on advocacy for nutrition, national and international health care disparities, health care delivery, and advanced access to cardiac imaging.